![](/img/cover-not-exists.png)
A phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head & neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT)
D.M. Brizel, T. Herman, D. Goffinet, S. Sailer, S. Agarwala, G. Schwartz, V. Venkatesan, C. Cripps, R.F. Meredith, E. Logan, B. YaoVolume:
51
Year:
2001
Language:
english
DOI:
10.1016/s0360-3016(01)01896-x
File:
PDF, 20 KB
english, 2001